InspireMD’s Upcoming Presentation at an International Conference
InspireMD, Inc. (Nasdaq: NSPR), renowned for developing the CGuard® Prime carotid stent system that aims to prevent strokes, is gearing up for a significant event at the H.C. Wainwright 27th Annual Global Investment Conference. The conference will take place on September 10, and InspireMD is set to present at 10:00 AM Eastern Time (ET).
About InspireMD and Its Innovative Technology
InspireMD has positioned itself as a key player in cardiovascular health, focusing particularly on carotid stenting. The company's proprietary MicroNet™ mesh technology is a cornerstone of its product offerings, engineered to enhance the effectiveness and safety of stent procedures. InspireMD aims to establish its stenting solutions as the standard in the industry, aspiring to deliver not just immediate procedural success but also long-term stroke-free outcomes for patients.
The Significance of the H.C. Wainwright Conference
This conference is a crucial platform for InspireMD to present its innovations and strategies to a wide audience of potential investors and industry peers. The dialogue around advancements in stroke prevention and cardiovascular technologies remains critical as healthcare solutions continuously evolve, and InspireMD is at the forefront of this evolution.
Accessing the Presentation
For those interested in following InspireMD’s presentation, a live audio webcast will be available, ensuring that anyone interested can tune in to hear the latest updates from the company. Following the live event, a replay will also be accessible for convenience.
Ongoing Commitments to Investors
InspireMD is committed to transparency and communication with its investors. The company regularly updates its website with vital information concerning its progress and achievements. The ongoing dialogue with stakeholders is essential in fostering trust and support as it navigates the competitive landscape of medical technology.
Contact Details for Investor Inquiries
For investor inquiries, InspireMD provides a direct line to investor relations through their contact Webb Campbell at Gilmartin Group LLC. Interested parties can reach out via email at webb@gilmartinir.com or investor-relations@inspiremd.com. These avenues ensure that investors can remain informed and engaged with the latest developments.
Frequently Asked Questions
What is InspireMD's primary focus?
InspireMD focuses on developing innovative solutions for carotid stenting using its proprietary technology aimed at preventing strokes.
When is InspireMD presenting at the H.C. Wainwright Conference?
InspireMD is scheduled to present on September 10 at 10:00 AM Eastern Time.
Where can I watch InspireMD's presentation?
A live audio webcast of the presentation will be available on InspireMD's website, along with a replay afterwards.
Who can I contact for investor relations information?
Investors can get in touch with Webb Campbell at Gilmartin Group LLC via email.
How does InspireMD aim to improve patient outcomes?
Through its MicroNet™ mesh technology, InspireMD aims to enhance the efficiency and safety of carotid stenting procedures, leading to better long-term health outcomes for patients.
